NewsBenzingaSenti Biosciences dépose un prospectus couvrant la revente de jusqu'à 25 555 024 actions ordinaires offertes par les détenteurs de titres vendus. Senti Biosciences dépose un prospectus couvrant la revente de jusqu'à 25 555 024 actions ordinaires offertes par les détenteurs de titres vendus. Benzinga 2026.09.24 21:01 (GMT+0) Open on Benzinga Other news Here's How Much $1000 Invested In Mercury System 20 Years Ago Would Be Worth Today Full Transcript: Costco Wholesale Q4 2026 Earnings Call Shuttle Pharmaceuticals Q2 EPS $(3.10) Up From $(32.90) YoY 'Anthropic Seeks Palantir-Style Voting Control For Seven Co-Founders Ahead Of IPO; Anthropic Planning To Give Founders 50.1% Voting Control In New Corporate Structure' - The Information CenterPoint Energy Secures $50M DOE Award For Advanced Substation Upgrades Here's How Much $1000 Invested In APi Group 5 Years Ago Would Be Worth Today
'Anthropic Seeks Palantir-Style Voting Control For Seven Co-Founders Ahead Of IPO; Anthropic Planning To Give Founders 50.1% Voting Control In New Corporate Structure' - The Information
